Transgenic zebrafish embryos to evaluate the in vivo effects of different liposome-paclitaxel nanocarrier system
Abstract Zebrafish is an established valuable model for understanding the complex in vivo behavior of systemic nanocarrier strategies, their safety profile, and the array of possible compositions. To date, we have explored the possibility of Paclitaxel (PTX) delivery using liposome systems as a prom...
Saved in:
| Main Authors: | Andrea Persico, Laura Molteni, Paride Mantecca, Marcelo Kravicz, Cinzia Bragato |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-00258-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Zebrafish Embryo as an Emerging Model Organism in Neurodevelopmental Toxicity Research
by: Şükriye Çalışkan, et al.
Published: (2021-12-01) -
Transformative Impact of Nanocarrier‐Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons
by: Minhye Kim, et al.
Published: (2024-11-01) -
Exploring the anticancer potential of green silver Nanoparticles–Paclitaxel nanocarrier on MCF-7 breast Cancer cells: an in vitro approach
by: M. Bassam Aboul-Nasr, et al.
Published: (2025-06-01) -
Enhanced in vivo Stability and Antitumor Efficacy of PEGylated Liposomes of Paclitaxel Palmitate Prodrug
by: Wu X, et al.
Published: (2024-11-01) -
PEGylated Liposomes of Disulfiram and Paclitaxel: A Promising Chemotherapeutic Combination Against Chemoresistant Breast Cancer
by: Ammar Said Suliman, et al.
Published: (2025-03-01)